Baseline Factors Predictive of the Receipt of Second-Line Chemotherapy After Nab-Paclitaxel Plus Gemcitabine for Patients With Advanced Pancreatic Cancer-Reference-Cited by-同舟云学术

Baseline Factors Predictive of the Receipt of Second-Line Chemotherapy After Nab-Paclitaxel Plus Gemcitabine for Patients With Advanced Pancreatic Cancer

Published:2022-03 Issue:3 Volume:51 Page:278-281
ISSN:1536-4828
Container-title:Pancreas
language:en
Short-container-title:Pancreas

Author:

Iede Kiyotsugu,Yamada Terumasa,Koh Masahiro,Ueda Masami,Tsuda Yujiro,Nakashima Shinsuke,Ohta Katsuya,Tanida Tsukasa,Matsuyama Jin,Ikenaga Masakazu,Tominaga Shusei

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Endocrinology,Hepatology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Reference20 articles.

1. Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial;J Clin Oncol,1997

2. Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine;N Engl J Med,2013

3. Modified FOLFIRINOX as a second-line therapy following gemcitabine plus nab-paclitaxel therapy in metastatic pancreatic cancer;BMC Cancer,2020

4. FOLFIRINOX for advanced pancreatic cancer patients after nab-paclitaxel plus gemcitabine failure;Pancreas,2020

5. Efficacy of S-1 in second-line chemotherapy after nab-paclitaxel plus gemcitabine for patients with advanced pancreatic cancer;Cancer Rep (Hoboken),2020

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hypoalbuminemia and hypercalcemia are independently associated with poor treatment outcomes of anti-PD-1 immune checkpoint inhibitors in patients with recurrent or metastatic head and neck squamous cell carcinoma;World Journal of Surgical Oncology;2024-09-11

2. Pancreatic cancer and sarcopenia: a narrative review of the current status;International Journal of Clinical Oncology;2024-07-02

3. Clinical Significance of Increased Skeletal Muscle Mass During Nab-Paclitaxel Plus Gemcitabine Treatment in Patients With Advanced Pancreatic Cancer;Pancreas;2023-12-28

4. Comparison of different second line treatments for metastatic pancreatic cancer: a systematic review and network meta-analysis;BMC Gastroenterology;2023-06-19

5. The association between albumin levels and survival in patients treated with immune checkpoint inhibitors: A systematic review and meta-analysis;Frontiers in Molecular Biosciences;2022-12-02